Search company, investor...

VisEn Medical

visenmedical.com

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$17.57M

About VisEn Medical

Visen Medical offers products for monitoring metabolic changes in the microenvironment surrounding cells in a tissue culture plate [fka Thermogenic Imaging]

Headquarters Location

45 Wiggins Avenue

Bedford, Massachusetts, 01730,

United States

781-932-6875

Missing: VisEn Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: VisEn Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

VisEn Medical Patents

VisEn Medical has filed 39 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Molecular biology
  • Microscopy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/16/2019

12/7/2021

Molecular biology, Microscopy, Spectroscopy, Medical imaging, Biotechnology

Grant

Application Date

10/16/2019

Grant Date

12/7/2021

Title

Related Topics

Molecular biology, Microscopy, Spectroscopy, Medical imaging, Biotechnology

Status

Grant

VisEn Medical Frequently Asked Questions (FAQ)

  • When was VisEn Medical founded?

    VisEn Medical was founded in 2000.

  • Where is VisEn Medical's headquarters?

    VisEn Medical's headquarters is located at 45 Wiggins Avenue, Bedford.

  • What is VisEn Medical's latest funding round?

    VisEn Medical's latest funding round is Acquired.

  • How much did VisEn Medical raise?

    VisEn Medical raised a total of $17.57M.

  • Who are the investors of VisEn Medical?

    Investors of VisEn Medical include PerkinElmer, Bollard Group, Flagship Pioneering, SpinnAker Capital, Siemens and 4 more.

  • Who are VisEn Medical's competitors?

    Competitors of VisEn Medical include CyrusOne, Optovue, Axion BioSystems, Intuity Medical, Celsense and 10 more.

Compare VisEn Medical to Competitors

Axion BioSystems Logo
Axion BioSystems

Axion BioSystems is a life science instrumentation company that develops high-throughput microelectrode array (MEA) systems for cellular analysis, allowing researchers to recreate brain activity and heartbeats on the benchtop. As a result, drug safety, drug discovery, and disease modeling is accomplished with greater sensitivity, accuracy, and productivity.

CyrusOne Logo
CyrusOne

CyrusOne (NASDAQ: CONE) is an owner, operator, and developer of Enterprise-class and carrier-neutral data center properties. Enterprise-class, carrier-neutral data centers are purpose-built facilities with redundant power, cooling, and telecommunications systems and that are not network-specific, enabling customer interconnectivity to a range of telecommunications carriers.

Intuity Medical Logo
Intuity Medical

Intuity Medical seeks to simplify diabetes management for persons living with diabetes. The company is developing a blood glucose monitoring system designed to make testing easy, convenient and discreet.

T
Tribo Flow Separations

Tribo Flow is developing an technique and sensors to detect in real time the metabolic activity of microbes and cells and their susceptibility to either drug treatments or viral infections.

C
Celsense

Celsense is a biotechnology company offering MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with pharmaceutical and biotechnology organizations and is developing products suitable for human use.

M
Mercator MedSystems

Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.